Evaluation of Oral Screen Training With IQoro as Treatment for Dysphagia After Stroke
NCT ID: NCT04868955
Last Updated: 2021-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
24 participants
INTERVENTIONAL
2019-04-26
2021-05-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Method Inpatient from a stroke unit in Sweden who have been assessed with fiberoptic endoscopic evaluation of swallowing(FEES) which proves swallowing difficulties (dysphagia) were recruited. The participants were randomise to control- or intervention group. Both groups received usual care. The intervention group were instructed to oral screen (IQoro®) training for 13 weeks. Follow up with FEES was made 13 weeks post of recruitment. The assess with FEES was recorded and the recordings are going to be analyzed afterwards to compare the swallowing ability between baseline and follow up in group and between group.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dysphagia Evaluation After Stroke- Effect Oral Neuromuscular Training on Swallowing Dysfunction
NCT02960737
Oral Screens in Post Stroke Training
NCT03167892
Swallow Training with Biofeedback in Acute Post Stroke Dysphagia
NCT05744245
The Impact of Diaphragm Training on Dysphagia in Bulbar Palsy After Ischemic Stroke
NCT06393218
Feasibility Study of Biofeedback in Dysphagia Therapy Post Stroke
NCT03499574
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
Usual care and oral screen (IQoro®) training.
Oral screen training
Oral screen training (IQoro®) during 13 weeks.
Control group
Usual care.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oral screen training
Oral screen training (IQoro®) during 13 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient assessed to have dysphagia (score ≥1 on one of the studied parameters)according to FEES.
* Patient who is able to handle IQoro® according to instructions, independently or with support of assistance from relatives or staff.
Exclusion Criteria
* Patient with impaired cognitive skill, motor and / or language ability that prevents the possibility of performing training with IQoro®, despite possible support from assistance from relatives or staff.
* Patient who wishes training with the Muppy oral screen® related to saliva leakage.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rebecca Norrman and Elin Rova
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rebecca Norrman and Elin Rova
Speech and language pathologists
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rebecca U Norrman, Master
Role: PRINCIPAL_INVESTIGATOR
Ostergotland County Council, Sweden
Elin AM Rova, Master
Role: PRINCIPAL_INVESTIGATOR
Ostergotland County Council, Sweden
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vrinnevisjukhuset
Norrköping, Östergötland County, Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-00636
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.